Data / Drug companies / Wavelength Enterprises LTD
Wavelength Enterprises LTD: 47 products in the FDA NDC directory, labeler code 58175
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Wavelength Enterprises LTD (labeler code 58175) lists 47 products in the FDA National Drug Code Directory. By type: 47 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on January 12, 2025.
The request: Watch Wavelength Enterprises LTD (FDA labeler code 58175): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 58175
- Products in commercial distribution
- 47
- Packages
- 48
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Controlled substance products
- Schedule IV 4, Schedule V 1
- Started marketing in the last 12 months
- 0
- Products with a marketing end date set
- 1
- Earliest marketing start
- January 1, 2000
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 47 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 47 | 100% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 46 | 97.9% |
| Liquid | 1 | 2.1% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Podofilox | 58175-0664 | Powder | Bulk ingredients | January 12, 2025 |
| Ganaxolone | 58175-0654 | Powder | Bulk ingredients | November 15, 2023 |
| Clascoterone | 58175-0650 | Powder | Bulk ingredients | December 30, 2022 |
| Remimazolam besylate | 58175-0648 | Powder | Bulk ingredients | August 31, 2022 |
| D9-tetrahydrocannabinol-naphthoylester | 58175-0644 | Powder | Bulk ingredients | April 15, 2022 |
| Tapinarof | 58175-0646 | Powder | Bulk ingredients | March 15, 2022 |
| Cantharidin | 58175-0642 | Powder | Bulk ingredients | April 1, 2021 |
| Pralidoxime chloride | 58175-0640 | Powder | Bulk ingredients | February 1, 2021 |
| Sitagliptin phosphate monohydrate | 58175-0638 | Powder | Bulk ingredients | September 1, 2020 |
| Naltrexone hydrochloride | 58175-0632 | Powder | Bulk ingredients | September 1, 2019 |
| Naltrexone base | 58175-0628 | Powder | Bulk ingredients | June 1, 2019 |
| Umeclidinium bromide | 58175-0626 | Powder | Bulk ingredients | April 1, 2019 |
| Glycopyrronium bromide | 58175-0624 | Powder | Bulk ingredients | April 1, 2019 |
| Crisaborole | 58175-0622 | Powder | Bulk ingredients | April 1, 2019 |
| Sitagliptin phosphate | 58175-0620 | Powder | Bulk ingredients | April 1, 2019 |
| Sugammadex | 58175-0618 | Powder | Bulk ingredients | August 30, 2018 |
| Fexofenadine hydrochloride | 58175-0616 | Powder | Bulk ingredients | November 30, 2017 |
| Tavaborole | 58175-0614 | Powder | Bulk ingredients | August 15, 2016 |
| Efinaconazole | 58175-0606 | Powder | Bulk ingredients | May 15, 2015 |
| Permethrin | 58175-0604 | Liquid | Bulk ingredients | May 15, 2015 |
| Ibrutinib | 58175-0602 | Powder | Bulk ingredients | December 30, 2014 |
| Fulvestrant | 58175-0600 | Powder | Bulk ingredients | August 1, 2014 |
| Tiotropium bromide | 58175-0565 | Powder | Bulk ingredients | December 12, 2011 |
| Rotigotine | 58175-0545 | Powder | Bulk ingredients | June 7, 2010 |
| Cisatracurium besylate | 58175-0541 | Powder | Bulk ingredients | April 30, 2010 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.